vs
Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $110.6M, roughly 1.4× American Assets Trust, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs 6.1%, a 65.1% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 1.8%).
Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
AAT vs STOK — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.6M | $158.6M |
| Net Profit | $6.7M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | 23.4% | 70.2% |
| Net Margin | 6.1% | 71.2% |
| Revenue YoY | 1.8% | 3661.1% |
| Net Profit YoY | -16.3% | 528.0% |
| EPS (diluted) | $0.08 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | — | ||
| Q3 25 | $109.6M | — | ||
| Q2 25 | $107.9M | — | ||
| Q1 25 | $108.6M | $158.6M | ||
| Q4 24 | $113.5M | $22.6M | ||
| Q3 24 | $122.8M | — | ||
| Q2 24 | $110.9M | — |
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $4.5M | — | ||
| Q2 25 | $5.5M | — | ||
| Q1 25 | $42.5M | $112.9M | ||
| Q4 24 | — | $-10.5M | ||
| Q3 24 | $16.7M | — | ||
| Q2 24 | $11.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 62.6% | — | ||
| Q1 25 | 62.0% | — | ||
| Q4 24 | 61.3% | — | ||
| Q3 24 | 65.5% | — | ||
| Q2 24 | 63.6% | — |
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 24.1% | — | ||
| Q1 25 | 66.3% | 70.2% | ||
| Q4 24 | 26.5% | -60.4% | ||
| Q3 24 | 30.8% | — | ||
| Q2 24 | 27.8% | — |
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 39.2% | 71.2% | ||
| Q4 24 | — | -46.4% | ||
| Q3 24 | 13.6% | — | ||
| Q2 24 | 10.7% | — |
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | — | ||
| Q3 25 | $0.07 | — | ||
| Q2 25 | $0.09 | — | ||
| Q1 25 | $0.70 | $1.90 | ||
| Q4 24 | $0.14 | $-0.15 | ||
| Q3 24 | $0.28 | — | ||
| Q2 24 | $0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.3M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | $350.1M |
| Total Assets | $2.9B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | — | ||
| Q3 25 | $138.7M | — | ||
| Q2 25 | $143.7M | — | ||
| Q1 25 | $143.9M | $274.8M | ||
| Q4 24 | $425.7M | $128.0M | ||
| Q3 24 | $533.0M | — | ||
| Q2 24 | $114.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | $350.1M | ||
| Q4 24 | $1.2B | $229.0M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — |
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | — | ||
| Q3 25 | $2.9B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.0B | $406.9M | ||
| Q4 24 | $3.3B | $271.6M | ||
| Q3 24 | $3.4B | — | ||
| Q2 24 | $3.0B | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $131.8M |
| Free Cash FlowOCF − Capex | — | $131.7M |
| FCF MarginFCF / Revenue | — | 83.0% |
| Capex IntensityCapex / Revenue | 14.5% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | — | ||
| Q3 25 | $40.5M | — | ||
| Q2 25 | $49.2M | — | ||
| Q1 25 | $36.9M | $131.8M | ||
| Q4 24 | $207.1M | $-23.2M | ||
| Q3 24 | $52.4M | — | ||
| Q2 24 | $59.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | — | ||
| Q3 25 | $23.1M | — | ||
| Q2 25 | $28.4M | — | ||
| Q1 25 | $20.4M | $131.7M | ||
| Q4 24 | $136.9M | $-23.2M | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $43.6M | — |
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | — | ||
| Q3 25 | 21.1% | — | ||
| Q2 25 | 26.3% | — | ||
| Q1 25 | 18.8% | 83.0% | ||
| Q4 24 | 120.7% | -102.7% | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 39.3% | — |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 15.1% | 0.1% | ||
| Q4 24 | 61.9% | 0.2% | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 14.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 8.98× | — | ||
| Q2 25 | 9.01× | — | ||
| Q1 25 | 0.87× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.15× | — | ||
| Q2 24 | 4.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
STOK
Segment breakdown not available.
